Buy Maball : Rituximab 100 mg/10 ml Injection Online

Description

Maball is an injectable medication manufactured by Hetero Ltd., designed to provide therapeutic benefits in the management of certain types of cancer and autoimmune diseases. Each vial contains 100 mg of Rituximab in a 10 ml solution.

Key Features:

1. Active Ingredient: Maball contains Rituximab, a monoclonal antibody that targets CD20 antigen present on the surface of B-cells. This mechanism of action makes it effective in treating various conditions, including non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and certain autoimmune disorders.
2. Concentration: Each vial of Maball contains a precise concentration of 100 mg of Rituximab in a 10 ml solution, ensuring accurate dosing and administration.
3. Manufactured by Hetero Ltd.: Maball is manufactured by Hetero Ltd., a reputable pharmaceutical company known for its high-quality products and adherence to stringent manufacturing standards. Hetero Ltd. employs advanced technology and rigorous quality control measures in the production of pharmaceuticals.

Indications:

• Maball is indicated for the treatment of various conditions, including:
  • Non-Hodgkin’s lymphoma (NHL): Maball is used in combination with chemotherapy for the treatment of certain types of NHL, including follicular lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma.
  • Chronic lymphocytic leukemia (CLL): Maball, in combination with chemotherapy, is indicated for the treatment of CLL.
  • Rheumatoid arthritis: Maball is used in combination with methotrexate for the treatment of moderate to severe rheumatoid arthritis in adult patients who have inadequate response to other disease-modifying antirheumatic drugs (DMARDs).
  • Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA): Maball, in combination with glucocorticoids, is indicated for the treatment of GPA and MPA in adult patients.

Dosage and Administration:

• The dosage of Maball and the treatment regimen may vary depending on the indication and the patient’s individual factors.
• Maball is administered intravenously by a healthcare professional experienced in the administration of chemotherapy or immunotherapy.
• Dosage adjustments and administration schedules should be determined by the treating physician based on the patient’s response to treatment and tolerability.

Storage Information:

• Maball should be stored under refrigeration at a temperature of 2°C to 8°C (36°F to 46°F).
• Do not freeze Maball. Protect the vials from light.
• Once removed from refrigeration, Maball should be used within a specified timeframe or according to the manufacturer’s instructions.

Precautions and Warnings:

• Maball should be administered under the supervision of a qualified healthcare professional experienced in the use of immunosuppressive agents.
• Patients should be monitored closely for signs of infusion reactions, infections, and other adverse effects during and after treatment with Maball.
• Use caution in patients with a history of hepatitis B virus (HBV) infection, as reactivation of HBV may occur during treatment with Rituximab.

Disclaimer:

• Maball Rituximab 100 mg/10 ml Injection is a prescription medication. Patients should consult their healthcare provider before starting treatment with Maball.
• This product description provides general information about Maball and is not intended to replace medical advice. Patients should seek advice from their healthcare provider regarding their specific medical condition and treatment options.